Is povidone-iodine pleurodesis as effective, safe and well tolerated as talc pleurodesis for recurrent malignant pleural effusions?

被引:1
作者
Bonser, Sophie A. [1 ,3 ]
Zhu, Michael Z. L. [2 ]
McKay, Glenn S. [2 ]
机构
[1] Royal Perth Hosp, Dept Gen Surg, Perth, WA, Australia
[2] Canberra Hosp, Dept Cardiothorac Surg, Canberra, ACT, Australia
[3] Royal Perth Hosp, Dept Gen Surg, Perth, WA 6000, Australia
来源
INTERDISCIPLINARY CARDIOVASCULAR AND THORACIC SURGERY | 2024年 / 38卷 / 01期
基金
英国医学研究理事会;
关键词
Malignant pleural effusion; Pleurodesis; Povidone-iodine; Talc;
D O I
10.1093/icvts/ivad192
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A best evidence topic in thoracic surgery was written according to a structured protocol. The question addressed was 'For patients with malignant pleural effusion is chemical pleurodesis with povidone-iodine as effective, safe and well tolerated as talc pleurodesis for prevention of recurrent malignant pleural effusions?'. A total of 124 papers were found during the search, of which 8 represented the best evidence to answer the clinical question. The authors, journal, date, country of publication, patient group studied, study type, relevant outcomes and results of these papers were tabulated. At present, medical-grade talc is the most commonly used agent for chemical pleurodesis due to its high success rate, extensive history of clinical use and well-known side-effect profile. However, studies using povidone-iodine seek to establish it as a readily available,low-cost alternative to talc that can be easily administered through an intercostal catheter at the bedside. The summation of available evidence suggests that povidone-iodine is a safe, well-tolerated and equally efficacious agent for pleurodesis in the setting of malignant pleural effusion, when compared to talc. A best evidence topic was constructed according to a structured protocol.
引用
收藏
页数:7
相关论文
共 9 条
[1]   A randomized controlled trial of the efficacy of cosmetic talc compared with iodopovidone for chemical pleurodesis [J].
Agarwal, Ritesh ;
Paul, Abinash S. ;
Aggarwal, Ashutosh N. ;
Gupta, Dheeraj ;
Jindal, Surinder K. .
RESPIROLOGY, 2011, 16 (07) :1064-1069
[2]  
Das Sibes Kumar, 2008, J Indian Med Assoc, V106, P589
[3]   Interventions for the management of malignant pleural effusions: a network meta-analysis [J].
Dipper, Alexandra ;
Jones, Hayley E. ;
Bhatnagar, Rahul ;
Preston, Nancy J. ;
Maskell, Nick ;
Clive, Amelia O. .
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2020, (04)
[4]  
Dunning Joel, 2003, Interact Cardiovasc Thorac Surg, V2, P405, DOI 10.1016/S1569-9293(03)00191-9
[5]   Povidone-iodine pleurodesis versus talc pleurodesis in preventing recurrence of malignant pleural effusion [J].
Ibrahim, Islam M. ;
Dokhan, Ahmed L. ;
El-Sessy, Alaa A. ;
Eltaweel, Mohammed F. .
JOURNAL OF CARDIOTHORACIC SURGERY, 2015, 10
[6]   Local iodine pleurodesis versus thoracoscopic talc insufflation in recurrent malignant pleural effusion: a prospective randomized control trial [J].
Mohsen, Tarek A. ;
Abou Zeid, Amany A. ;
Meshref, Mohamed ;
Tawfeek, Nehad ;
Redmond, Karen ;
Ananiadou, Olga G. ;
Haj-Yahia, Saleem .
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2011, 40 (02) :282-286
[7]   Iodopovidone pleurodesis for malignant pleural effusions: an updated systematic review and meta-analysis [J].
Muthu, Valliappan ;
Dhooria, Sahajal ;
Sehgal, Inderpaul Singh ;
Prasad, Kuruswamy Thurai ;
Aggarwal, Ashutosh N. ;
Agarwal, Ritesh .
SUPPORTIVE CARE IN CANCER, 2021, 29 (08) :4733-4742
[8]  
Nistor C, 2014, FARMACIA, V62, P897
[9]   Chemical pleurodesis for malignant pleural effusion [J].
Shouman, W. ;
Elgazzar, A. ;
Hussien, R. M. ;
ElShaaray, M. ;
Light, R. W. .
EGYPTIAN JOURNAL OF CHEST DISEASES AND TUBERCULOSIS, 2012, 61 (03) :115-120